![](/img/cover-not-exists.png)
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer
Nishina, Tomohiro, Kato, Takeshi, Yamazaki, Kentaro, Yoshino, Takayuki, Miyata, Yoshinori, Esaki, Taito, Moriwaki, Toshikazu, Boku, Narikazu, Hyodo, IchinosukeVolume:
76
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-015-2825-5
Date:
September, 2015
File:
PDF, 568 KB
english, 2015